HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Daniela Impellizzeri Selected Research

2-pentadecyl-2-oxazoline

1/2022Assessment of 2-Pentadecyl-2-oxazoline Role on Lipopolysaccharide-Induced Inflammation on Early Stage Development of Zebrafish (Danio rerio).
1/2020Effect of N-palmitoylethanolamine-oxazoline on comorbid neuropsychiatric disturbance associated with inflammatory bowel disease.
9/2019N-Palmitoylethanolamide-Oxazoline Protects against Middle Cerebral Artery Occlusion Injury in Diabetic Rats by Regulating the SIRT1 Pathway.
1/2019N-Palmitoylethanolamine-oxazoline (PEA-OXA): A new therapeutic strategy to reduce neuroinflammation, oxidative stress associated to vascular dementia in an experimental model of repeated bilateral common carotid arteries occlusion.
12/20182-Pentadecyl-2-Oxazoline Reduces Neuroinflammatory Environment in the MPTP Model of Parkinson Disease.
9/2018Effect of PEA-OXA on neuropathic pain and functional recovery after sciatic nerve crush.
1/2017N-Palmitoylethanolamine-Oxazoline as a New Therapeutic Strategy to Control Neuroinflammation: Neuroprotective Effects in Experimental Models of Spinal Cord and Brain Injury.
1/20172-Pentadecyl-2-Oxazoline, the Oxazoline of Pea, Modulates Carrageenan-Induced Acute Inflammation.
1/20162-pentadecyl-2-oxazoline: Identification in coffee, synthesis and activity in a rat model of carrageenan-induced hindpaw inflammation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Daniela Impellizzeri Research Topics

Disease

58Inflammation (Inflammations)
05/2022 - 09/2010
26Pain (Aches)
05/2022 - 08/2014
19Spinal Cord Injuries (Spinal Cord Injury)
01/2019 - 09/2010
18Neuroinflammatory Diseases
04/2022 - 01/2011
17Edema (Dropsy)
10/2022 - 05/2012
17Hyperalgesia
05/2022 - 08/2014
11Wounds and Injuries (Trauma)
04/2022 - 02/2011
9Ischemia
06/2022 - 01/2011
9Colitis
02/2022 - 12/2015
8Traumatic Brain Injuries (Traumatic Brain Injury)
04/2022 - 11/2012
7Reperfusion Injury
09/2020 - 01/2011
7Myelitis
01/2014 - 09/2010
6Arthritis (Polyarthritis)
10/2022 - 10/2011
6Endometriosis
05/2022 - 07/2018
6Fibrosis (Cirrhosis)
04/2022 - 07/2011
6Pulmonary Fibrosis (Fibrosing Alveolitis)
11/2021 - 07/2011
6Pneumonia (Pneumonitis)
07/2021 - 03/2011
6Body Weight (Weight, Body)
01/2020 - 07/2011
5Experimental Arthritis
10/2022 - 10/2011
5Brain Injuries (Brain Injury)
06/2022 - 10/2012
5Fibromyalgia (Fibrositis)
05/2022 - 12/2019
5Parkinson Disease (Parkinson's Disease)
05/2022 - 01/2012
5Weight Loss (Weight Reduction)
10/2020 - 01/2016
5Lung Injury
10/2020 - 07/2011
5Shock
09/2020 - 11/2010
4Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
03/2021 - 12/2015
4Pancreatitis
10/2020 - 05/2012
4Osteoarthritis
10/2020 - 12/2016
4Aneurysm (Aneurysms)
01/2019 - 11/2011
3Vascular Dementia (Subcortical Arteriosclerotic Encephalopathy)
06/2022 - 01/2017
3Neurodegenerative Diseases (Neurodegenerative Disease)
10/2021 - 10/2015
3Neoplasms (Cancer)
05/2021 - 04/2012
3Neuralgia (Stump Neuralgia)
02/2021 - 09/2018
3Necrosis
09/2020 - 10/2011
3Brain Ischemia (Cerebral Ischemia)
09/2019 - 06/2013
3Stroke (Strokes)
10/2015 - 10/2012
3Pleurisy (Pleuritis)
10/2011 - 03/2011

Drug/Important Bio-Agent (IBA)

41palmidrolIBA
10/2021 - 01/2012
21CytokinesIBA
05/2022 - 09/2010
20AntioxidantsIBA
05/2022 - 07/2013
14CarrageenanIBA
05/2022 - 03/2011
13Peroxidase (Myeloperoxidase)IBA
08/2021 - 09/2010
92-pentadecyl-2-oxazolineIBA
01/2022 - 01/2016
9Neuroprotective AgentsIBA
10/2019 - 02/2013
93-nitrotyrosineIBA
01/2018 - 09/2010
8Bleomycin (Blenoxane)FDA LinkGeneric
05/2022 - 07/2011
8LuteolinIBA
01/2017 - 01/2013
7Analgesics (Analgesic Drugs)IBA
05/2022 - 11/2016
7Peroxisome Proliferator-Activated Receptors (PPAR)IBA
02/2021 - 04/2012
7adelmidrolIBA
07/2020 - 11/2016
6DinitrobenzenesIBA
03/2021 - 12/2015
62,4-dinitrofluorobenzene sulfonic acidIBA
03/2021 - 12/2015
6co-ultraPEALutIBA
01/2019 - 07/2013
5Collagen Type II (Type II Collagen)IBA
10/2022 - 10/2011
5Olive OilIBA
04/2022 - 08/2011
5NF-kappa B (NF-kB)IBA
04/2022 - 09/2010
5Fatty Acids (Saturated Fatty Acids)IBA
03/2022 - 06/2012
5AmidesIBA
03/2022 - 08/2015
5Sulfonic AcidsIBA
03/2021 - 12/2015
5Proteins (Proteins, Gene)FDA Link
01/2021 - 05/2012
5Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA
01/2017 - 04/2012
4EnzymesIBA
04/2022 - 07/2012
4Reactive Oxygen Species (Oxygen Radicals)IBA
10/2021 - 04/2014
4P-SelectinIBA
08/2020 - 10/2011
4Formyl Peptide Receptors (Formyl Peptide Receptor)IBA
08/2020 - 07/2018
4Nerve Growth Factor (NGF)IBA
05/2020 - 08/2017
4Hyaluronic Acid (Hyaluronan)IBA
05/2020 - 12/2016
4oleuropein aglyconeIBA
02/2013 - 08/2011
3Reserpine (Serpasil)FDA Link
05/2022 - 12/2019
3CollagenIBA
04/2022 - 06/2016
3CateninsIBA
04/2022 - 06/2021
3LipopolysaccharidesIBA
01/2022 - 08/2017
3SodiumIBA
01/2022 - 08/2017
3AtrazineIBA
11/2021 - 07/2021
33,4-dihydroxyphenylethanol (hydroxytyrosol)IBA
11/2021 - 08/2020
3Biological ProductsIBA
11/2021 - 04/2014
3Ethanol (Ethyl Alcohol)IBA
11/2021 - 05/2012
3InflammasomesIBA
10/2021 - 03/2020
3Cyclophosphamide (Cytoxan)FDA LinkGeneric
06/2021 - 01/2018
3AcidsIBA
04/2021 - 04/2016
3CeruletideIBA
10/2020 - 05/2012
3Cell Adhesion MoleculesIBA
08/2020 - 10/2011
3Lipase (Acid Lipase)FDA Link
08/2020 - 05/2012
3AmylasesFDA Link
08/2020 - 05/2012
31- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA
12/2018 - 01/2012
3Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA
01/2018 - 04/2016
3PolyphenolsIBA
09/2015 - 05/2012
3triphenyltetrazoliumIBA
06/2013 - 10/2012
3olprinoneIBA
07/2011 - 09/2010
3NADPH Oxidases (NAD(P)H oxidase)IBA
07/2011 - 02/2011
3acetovanillone (apocynin)IBA
03/2011 - 11/2010
2Endocrine DisruptorsIBA
10/2022 - 05/2022
2Brain-Derived Neurotrophic Factor (BDNF)IBA
06/2022 - 06/2021
2Nerve Growth Factors (Neurotrophins)IBA
06/2022 - 01/2019

Therapy/Procedure

10Therapeutics
05/2022 - 01/2011
7Intraperitoneal Injections
04/2022 - 05/2012
7Laminectomy
01/2019 - 09/2010
6Oral Administration
02/2021 - 11/2019
4Injections
10/2022 - 06/2021
4Surgical Instruments (Clip)
01/2019 - 11/2011